Physician profile
Robert W Wake
NPI 1982661088
$1,150.37
in general payments reported to CMS, 2019-2025
12 companies · $62.82 in 2025
The $62.82 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $18.51 · 2021: $210 · 2022: $156 · 2023: $212 · 2024: $310 · 2025: $62.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $430.41 | 2019-2024 | Lithovue, Nephromax, Rezum Generator |
| Coloplast Corp | $158.77 | 2019-2024 | Titan |
| Teleflex LLC | $131.24 | 2022 | |
| Verity Pharmaceuticals INC. | $80.06 | 2023-2024 | Trelstar |
| Olympus America INC. | $67.18 | 2021 | |
| Pfizer INC. | $66.65 | 2021-2024 | |
| Healthtronics Stone Solutions, LLC | $66.22 | 2019 | |
| Astellas Pharma US INC | $42.72 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $33.88 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Endo USA, INC. | $28.94 | 2025 | Xiaflex |
| Abbvie INC. | $24.62 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.68 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.